TRCT
ROIVW

Tower Research Capital (TRC)’s Roivant Sciences Ltd. Warrant ROIVW Stock Holding History

Tower Research Capital (TRC)’s Portfolio ROIVW Stock Details ROIVW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-126
Closed -$312 – 6415
2023
Q2 		$312 Hold
126
– – ﹤0.01% 5697
2023
Q1 		$0 Hold
126
– – ﹤0.01% 6560
2022
Q4 		$0 Hold
126
– – ﹤0.01% 6643
2022
Q3 		$0 Hold
126
– – ﹤0.01% 6737
2022
Q2 		$0 Hold
126
– – ﹤0.01% 6777
2022
Q1 		$0 Hold
126
– – ﹤0.01% 6839
2021
Q4 		$0 Buy
+126
New +$192 ﹤0.01% 6777

Tower Research Capital (TRC)'s ROIVW Position: Q3 2023 in Review

Tower Research Capital (TRC) sold out of Roivant Sciences Ltd. Warrant (ROIVW) in Q3 2023, closing a stake of 126 shares — an estimated $312 sold.

Tower Research Capital (TRC) first reported a position in ROIVW in Q4 2021 and held it in 7 quarters. The position peaked at $312 in Q2 2023. 0 funds tracked by Wall St. Rank hold ROIVW as of Q3 2023.

  • Tower Research Capital (TRC) reported no remaining Roivant Sciences Ltd. Warrant position as of Q3 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 126 Roivant Sciences Ltd. Warrant shares in Q3 2023, an estimated $312.
  • Tower Research Capital (TRC) first reported a position in Roivant Sciences Ltd. Warrant in Q4 2021 and held it in 7 quarters.
  • Tower Research Capital (TRC)'s Roivant Sciences Ltd. Warrant position peaked at $312 in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Roivant Sciences Ltd. Warrant as of Q3 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2023, filed 14 Nov 2023.